Yttrium-90 radioembolization for neuroendocrine liver metastases: baseline vascularity predicts cytoreduction efficacy

Anne Frisch, Johannes Kahn, Federico Collettini, Peter Steinhagen, Uli Fehrenbach, Bernhard Gebauer, Holger Amthauer, Imke Schatka · 2026

Read Yttrium-90 radioembolization for neuroendocrine liver metastases: baseline vascularity predicts cytoreduction efficacy by Anne Frisch, Johannes Kahn, Federico Collettini, Peter Steinhagen, Uli Fehrenbach, Bernhard Gebauer, Holger Amthauer, Imke Schatka (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352018.txt.

Description

Frisch and colleagues reviewed a liver treatment for hormone-linked tumors that had spread from elsewhere in the body in a 2026 study. The treatment sends tiny radioactive beads through blood vessels into liver tumors. Thirty patients treated over seven years at one center were checked with scans before and after care.

Tumors with richer blood flow on early scans tended to shrink more after treatment. The team also weighed scan measures against how long patients lived, which averaged close to three years. Being able to receive a follow-on targeted therapy linked most strongly to longer life. Early blood flow on scans may help doctors pick who benefits most from the bead treatment.

Catalog record

CREATORAnne Frisch, Johannes Kahn, Federico Collettini, Peter Steinhagen, Uli Fehrenbach, Bernhard Gebauer, Holger Amthauer, Imke Schatka
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29364
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0352018

Browse the full library · About the Tower of Babel